Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event

doi:10.4251/wjgo.v14.i6.1103

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5353)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

289

WORD

HTML

3156

Figures (1-1)

208

Sum=3730

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

210

Download

490

Sum=700

Publishing Process of This Article

Item

Count

Browse

279

Download

644

Sum=923

Jun 15, 2022 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Jun 15, 2022; 14(6): 1103-1114
Published online Jun 15, 2022. doi: 10.4251/wjgo.v14.i6.1103

Open in New Tab Full Size Figure Download Figure

Figure 1 Common clinical features of fibrolamellar carcinoma upon presentation. AFP: Alpha-fetoprotein.

Citation: Abdelhamed W, El-Kassas M. Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event. World J Gastrointest Oncol 2022; 14(6): 1103-1114
URL: https://www.wjgnet.com/1948-5204/full/v14/i6/1103.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i6.1103